A FHIR-compliant Application for Multi-Site and Multi-Modality Pediatric Scoliosis Patient Rehabilitation

2021 ◽  
Author(s):  
Wenqi Shi ◽  
Felipe O. Giuste ◽  
Yuanda Zhu ◽  
Ashley M. Carpenter ◽  
Henry J. Iwinski ◽  
...  
Keyword(s):  
Scoliosis Patient

Erythropoietin and Desmopressin Obviated Transfusion in a Thromboasthenic Jehovah's Witness Undergoing Scoliosis Surgery

1996 ◽  
Vol 2 (1) ◽  
pp. 11-13
Author(s):  
Stefan Lethagen ◽  
Magnus K. Karlsson
Keyword(s):  
Blood Loss ◽  
Tranexamic Acid ◽  
Bleeding Time ◽  
Hemoglobin Concentration ◽  
Scoliosis Surgery ◽  
Scoliosis Patient ◽  
Platelet Dysfunction ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Erythropoietin Treatment

A 13-year-old female Jehovah's Witness with thromboasthenia was scheduled for scoliosis surgery. To reduce the risk of heterologous transfusion, she was given erythropoietin for 2 weeks preoperatively. Bleeding time and platelet dysfunction normalized during erythropoietin treatment, but the hemoglobin concentration increased only marginally. Desmopressin and tranexamic acid were given as cover for surgery. Blood loss was less than that in the average scoliosis patient, 1,490 ml as compared to 2,740 ml, and no heterologous transfusion was given. Erythropoietin may thus be given preoperatively, not only to increase the hemoglobin concentration, but also to improve the platelet function in thromboasthenic pa tients.

Sign in / Sign up

Export Citation Format

Share Document